外科理论与实践››2018,Vol. 23››Issue (03): 214-216.doi:10.16139/j.1007-9610.2018.03.007
李涛
收稿日期:2017-12-25发布日期:2020-07-25通讯作者:李涛,E-mail: litao7706@163.com基金资助:
Received:2017-12-25Published:2020-07-25| [1] Howard SC, Jones DP, Pui CH.The tumor lysis syndrome[J]. N Engl J Med,2011,364(19):1844-1854. [2] Coiffier B, Altman A, Pui CH, et al.Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review[J]. J Clin Oncol,2008,26(16):2767-2778. [3] Vodopivec DM, Rubio JE, Fornoni A, et al.An unusual presentation of tumor lysis syndrome in a patient with advanced gastric adenocarcinoma: case report and literature review[J]. Case Rep Med,2012,2012:468452. [4] Cairo MS, Bishop M.Tumour lysis syndrome: new therapeutic strategies and classification[J]. Br J Haematol,2004,127(1):3-11. [5] Chao CT, Chiang CK.Rasburicase for huge hepatocellular carcinoma with tumor lysis syndrome: case report[J]. Med Princ Pract,2012,21(5):498-500. [6] Bossé D, Marginean CE, Macdonald DB, et al. Tumour lysis syndrome in solid tumours associated with tyrosine kinase inhibitors-a case illustrated review[J]. Eur Oncol Haematol,2016,12:(1):51-54. [7] Paye F, Farges O, Dahmane M, et al.Cytolysis following chemoembolization for hepatocellular carcinoma[J]. Br J Surg,1999,86(2):176-180. [8] Joshita S, Yoshizawa K, Sano K, et al.A patient with advanced hepatocellular carcinoma treated with sorafenib tosylate showed massive tumor lysis with avoidance of tumor lysis syndrome[J]. Intern Med,2010,49(11):991-994. [9] Shiozawa K, Watanabe M, Takenaka H, et al.Tumor lysis syndrome after sorafenib for hepatocellular carcinoma: a case report[J]. Hepatogastroenterology,2010,57(101):688-690. [10] Huo TI, Wu JC, Lee PC, et al.Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study[J]. Liver Int,2004,24(3):210-215. [11] Kalemkerian GP, Darwish B, Varterasian ML.Tumor lysis syndrome in small cell carcinoma and other solid tumors[J]. Am J Med,1997,103(5):363-367. [12] Jiang RD, Jian WC, Jin N, et al.Tumor lysis syndrome: a serious complication of transcatheter arterial chemoembolization for hepatocellular carcinoma[J]. Am J Med,2016, 129(9):e173-e176. |
| [1] | 陈聪燕, 王俊青, 陈拥军.肠道菌群与肝癌的发病机制[J]. 外科理论与实践, 2022, 27(3): 256-260. |
| [2] | 章晓炎, 徐静, 璩斌.血清维生素D水平对老年慢性肾脏病患者肾功能的影响[J]. 内科理论与实践, 2022, 17(04): 307-312. |
| [3] | 朱小霞.浅谈痛风及高尿酸血症治疗热点问题[J]. 内科理论与实践, 2022, 17(03): 198-201. |
| [4] | 任家俊, 陈拥军.肝脾联合切除治疗原发性肝癌合并门静脉高压及脾功能亢进[J]. 外科理论与实践, 2022, 27(02): 139-144. |
| [5] | 汤钊猷.中华哲学思维对肝癌治疗的启迪[J]. 外科理论与实践, 2022, 27(02): 93-94. |
| [6] | 朱鹏, 廖威, 张必翔, 陈孝平.机器人肝癌肝切除应用现状与前景[J]. 外科理论与实践, 2022, 27(02): 95-99. |
| [7] | 曹君, 陈亚进.腹腔镜解剖性肝切除治疗肝癌的规范与思考[J]. 外科理论与实践, 2022, 27(02): 123-127. |
| [8] | 宋娟, 邢寅, 黄慧, 陆帅, 秦利.上海市崇明地区中老年人群血白细胞计数与血尿酸水平相关性研究[J]. 内科理论与实践, 2021, 16(06): 413-417. |
| [9] | 杨洋, 龚艳春.无症状高尿酸血症与心血管疾病和肾脏疾病关系的研究进展[J]. 内科理论与实践, 2021, 16(05): 366-370. |
| [10] | 吴冬梅, 吴丽莉, 陈佳, 刘坤.淋巴上皮样肝细胞肝癌一例报告附文献复习[J]. 诊断学理论与实践, 2021, 20(05): 498-501. |
| [11] | 苏长青.从基础研究到临床转化应用谈肝癌的诊治进展[J]. 诊断学理论与实践, 2021, 20(05): 427-433. |
| [12] | 祝洪明, 李啸扬, 普布旺堆, 巴顿, 方洁, 次仁央宗, 宗吉, 乐飞, 罗布卓玛.红细胞单采术治疗高原红细胞增多症合并高尿酸血症[J]. 内科理论与实践, 2021, 16(04): 267-269. |
| [13] | 徐丽梨, 王伟铭.特发性肾性低尿酸血症相关的急性肾衰竭一例报告及文献复习[J]. 诊断学理论与实践, 2021, 20(02): 213-215. |
| [14] | 汪楠, 郝风节, 王俊青.肝细胞多倍体发生机制及其与肝细胞癌形成的相关性研究进展[J]. 诊断学理论与实践, 2020, 19(06): 618-621. |
| [15] | 陈鹏, 李涛.胞外囊泡携带的非编码RNA在肝癌发生、发展中的作用[J]. 外科理论与实践, 2020, 25(05): 447-451. |
| 阅读次数 | ||||||
| 全文 |
|
|||||
| 摘要 |
|
|||||
